- Martin Shkreli, 32, founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim in August for $55million
- He raised the price of the drug form $13.50 per tablet to $750 per tablet
- Shkreli has backed the decision, saying that his company 'need to turn a profit on the drug'
- Daraprim treats toxoplasmois, an opportunistic parasitic infection that can cause serious and life-threatening problems
World-wide medical news for clinical use. Contributions edited by Dr.A.Franklin MBBS(Lond)Dip.Phys.Med (UK) DPH & DIH(Tor.)LMC(C) FLEx(USA) Fellow Med.Soc.London
21 September 2015
UK DAILY MAIL: SWISS firm TURING PHARM AB bought Marketing Rights to DARAPRIM (PYRIMETHAMINE)
Globe and Mail::Couple shot at expensive steakhouse MICHAEL'S ON SIMCOE.10pm Sunday (yesterday)
Two masked persons shot two diners at walk-in MICHAEL'S.100 Simcoe (W.of University;S on Adelaide)
Well-known steakhouse with ANGUS & KOBE beef.
Left-wing pressure on Toronto police to be kind to criminals.
Safest to eat in HOTELS with entrance`away from restaurant. Increasing violent crime in Toronto. .
Well-known steakhouse with ANGUS & KOBE beef.
Left-wing pressure on Toronto police to be kind to criminals.
Safest to eat in HOTELS with entrance`away from restaurant. Increasing violent crime in Toronto. .
Subscribe to:
Posts (Atom)